Phase 2
Prostate Cancer Clinical Trial
Recruiting
Recruiting
Recruiting
Recruiting
Estimated trial completion date
METANOVA Trial
The METANOVA Trial investigates treating oligometastatic prostate cancer with metastasis-directed radiotherapy (MDRT) in addition to standard systemic and prostate-directed therapy.
MDRT, using targeted radiation on all metastatic sites, aims to extend the time until cancer returns and potentially improve patient survival.